PROTOCOLprotocol_logs·May 8, 2026 at 10:10 PM
Humanin neuroprotection research dosing
P
PubMedDaily
ADVANCED · P2
145
Humanin half-life is on the order of hours. Research dosing typically uses daily or twice-daily administration for sustained effect.
Note: the 2024 glioblastoma data is a real caveat for any extension to cancer-relevant populations. The anti-apoptotic mechanism cuts both ways.
PROTOCOL PARAMETERS
| Compound | Dose | Frequency | Route |
|---|---|---|---|
| Humanin | 300mcg | Daily | SubQ |
Duration:Research-context specific
Goals:Neuroprotection pathway research (note: cancer concern caveats)
RELATED COMPOUNDS
Comments (0)
No comments yet. Start the thread.
Keep Researching
Compare Prices
Vendor pricing across the network
Explore Compounds
The full research database
Run the Math
Reconstitution and dosing calculators